Thought Leaders in Healthcare IT: Raj Agarwal, CEO of Medocity (Part 5)

Sramana Mitra: I’m just trying to understand the trends of this industry. If a technology provider is selling into the pharmaceutical industry in the digital therapeutics use case, how else is a digital therapeutics use case going to pan out commercially? Raj Agarwal: It’s early in the game. That’s a new trend. There are three

Read Full Article »

Featured Videos

Best of Bootstrapping: Why is Bootstrapping Important?

If you haven’t already, please study our Bootstrapping Course and Investor Introductions page.  Over the last decade and more, I’ve had the privilege of working with a large number of bootstrapped entrepreneurs. These include self-financed companies and also modestly capitalized startups that operate in a capital-efficient manner applying the principles of bootstrapping. [You can review my Bootstrapping Course to

Read Full Article »

Man and Superman: Augmentation of the Human Brain

As automation devastates the fundamental economic model of the human civilization, we are faced with the option of augmenting the human brain such that ALL unskilled, low-IQ humans become upgraded. I wrote on this topic last year: Man and Superman: Can Displaced Blue Collar Workers Become Doctors? Since then, Elon Musk has made public statements about

Read Full Article »

From Zero to a Market Cap Bigger than General Motors: Keith Krach, Founder of Ariba (Part 5)

Sramana Mitra: You were basically selling license software at this point right? Keith Krach: Yes, we were selling license software. We said, “If we’re ever going to do this again, we’re going to pull as much expense as we can and push as much revenue out as we can. When it came to recognized revenue,

Read Full Article »

Thought Leaders in Healthcare IT: Raj Agarwal, CEO of Medocity (Part 4)

Sramana Mitra: Let’s switch the discussion to pharmaceuticals and where drugs are now being enhanced by various kinds of digital monitoring or reporting. What are the trends there? It seems like you have penetration in that use case as well. Raj Agarwal: One big trend on the pharma side is that they are recognizing that

Read Full Article »

428th Roundtable Recording on January 16, 2019: With Ondrej Bartos, Credo Ventures

In case you missed it, you can listen to the recording here:

From Zero to a Market Cap Bigger than General Motors: Keith Krach, Founder of Ariba (Part 4)

Keith Krach: Benchmark fund number one ended up being the best-performing fund in history. We started it. We were going to an offsite. I said, “Paul, can you do a prototype?” He said, “I can’t do a prototype until we talk to a customer first.” I said, “How many do you think we should talk

Read Full Article »

Roundtable Recap: January 16 – Spotlight on Entrepreneurship in Central Europe

During this week’s roundtable, we had as our guest Ondrej Bartos, General Partner at Credo Ventures based in Prague, focused on investing in Central European startups. Their major success story is UiPath in robotics process automation that has raised $265 million at a $3 billion valuation. UiPath has over 2,100 customers and claims to have

Read Full Article »